Annamycin
Not to be confused with Ansamycin.
Systematic (IUPAC) name | |
---|---|
(7S,9S)-7-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-3-iodo- 6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9- (2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione | |
Identifiers | |
CAS Number | 92689-49-1 |
ATC code | none |
PubChem | CID 115212 |
ChemSpider | 103088 |
UNII | SNU299M83Q |
Chemical data | |
Formula | C26H25IO11 |
Molar mass | 640.375 g/mol |
| |
| |
(verify) |
Annamycin is an anthracycline antibiotic being investigated for the treatment of cancer.
Further reading
- Priebe W (1995). "Mechanism of action-governed design of anthracycline antibiotics: a "turn-off/turn-on" approach". Current Pharmaceutical Design 1 (1): 51–68.
- Trevino AV, Woynarowska BA, Herman TS, Priebe W, Woynarowski JM (November 2004). "Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline analogues". Mol Cancer Ther 3 (11): 1403–10. PMID 15542779.
External links
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.